Annual report pursuant to Section 13 and 15(d)

Consolidated Statement of Changes in Stockholders' Equity

v3.24.1.u1
Consolidated Statement of Changes in Stockholders' Equity - USD ($)
Common Stock [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Common Stock [Member]
Treasury Stock, Common [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Treasury Stock, Common [Member]
Additional Paid-in Capital [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Retained Earnings [Member]
Gaucho Group Holdings Stockholders Deficiency [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Gaucho Group Holdings Stockholders Deficiency [Member]
Noncontrolling Interest [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Noncontrolling Interest [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Total
Balance at Dec. 31, 2021   $ 823   $ (46,355)   $ 121,641,238   $ (11,607,446)   $ (95,726,534)   $ 14,261,726   $ (169,882)   $ 14,091,844
Balance, shares at Dec. 31, 2021   82,350   28                        
Stock-based compensation:                                
Options       259,611       259,611   10,354   269,965
Restricted stock units   $ 300     579,330       579,630     579,630
Restricted stock units, shares   30,000                            
Common stock   $ 54     524,946       525,000     525,000
Common stock, shares   5,421                            
Common stock issued for 401(k) employer matching   $ 1     27,820       27,821     27,821
Common stock issued for 401(k) employer matching, shares   104                            
Shares issued under the New ELOC   $ 10     10,076       10,086     10,086
Shares issued under the New ELOC, shares   1,000                            
Shares issued upon conversion of debt and interest   $ 2,021     7,903,540       7,905,561     7,905,561
Shares issued upon conversion of debt and interest, shares   202,082                            
Net loss           (21,753,037)   (21,753,037)   (72,261)   (21,825,298)
Other comprehensive income         764,877     764,877     764,877
Effect of reverse stock split   $ 8     (8)          
Effect of reverse stock split, shares   738                            
Common stock issued for cash, net of offering costs [1]   $ 50     511,296       511,346     511,346
Common stock issued for cash, net of offering costs, shares [1]   5,005                            
Substantial premium on convertible debt       1,683,847       1,683,847     1,683,847
Warrants issued for  modification of convertible debt principal       849,431       849,431     849,431
Inducement loss on debt conversions       3,163,318       3,163,318     3,163,318
Common stock issued for purchase of minority interest   $ 87     (231,876)       (231,789)   231,789  
Common stock issued for purchase of minority interest, shares   8,690                            
Common stock issued upon exchange of subsidiary stock options   $ 184     (184)          
Common stock issued upon exchange of subsidiary stock options, shares   18,394                            
Common stock issued for acquisition of GDS   $ 107     2,194,546       2,194,653     2,194,653
Common stock issued for acquisition of GDS, shares   10,695                            
Common stock issued for purchase of domain name   $ 9     39,591       39,600     39,600
Common stock issued for purchase of domain name, shares   861                            
Balance at Dec. 31, 2022   $ 3,654   $ (46,355)   139,156,522   (10,842,569)   (117,479,571)   10,791,681   10,791,681
Balance, shares at Dec. 31, 2022   365,340   28                        
Cumulative effect of change upon adoption of ASU 2016-13         $ (111,582)       (111,582)  
Stock-based compensation:                                
Options       113,487               113,487
Restricted stock units   $ 75     307,073               307,148
Restricted stock units, shares   7,482                            
Common stock   $ 270     149,730               150,000
Common stock, shares   27,027                            
Common stock issued for 401(k) employer matching   $ 24     32,593               32,617
Common stock issued for 401(k) employer matching, shares   2,416                            
Shares issued under the New ELOC [2]   $ 1,508     850,580           852,088
Shares issued under the New ELOC, shares [2]   150,684                            
Common stock and warrants issued for cash in private placement   $ 18,358     1,994,708               2,013,066
Common stock and warrants issued for cash in private placement, shares   1,835,790                            
Shares issued upon conversion of debt and interest   $ 23,803     5,886,945               5,910,748
Shares issued upon conversion of debt and interest, shares   2,380,338                            
Relative fair value of warrants issued with 2023 Notes, net of issuance costs [3]       1,506,319               1,506,319
Warrant modification       392,273               392,273
Warrants issued for modification of GGH Notes       134,779               134,779
Reduction of warrant exercise price on new debt issuance       63,502               63,502
Cashless warrant exercise   $ 51     (51)              
Cashless warrant exercise, shares   5,131                            
True-up adjustment                    
True-up adjustment, shares   28                            
Net loss           (16,198,010)     (16,198,010)
Other comprehensive income         (262,137)             (262,137)
Effect of reverse stock split   $ 336     (336)              
Effect of reverse stock split, shares   33,702                            
Balance at Dec. 31, 2023   $ 48,079   $ (46,355)   $ 150,588,124   $ (11,104,706)   $ (133,789,163)     $ 5,695,979
Balance, shares at Dec. 31, 2023   4,807,938   29                        
[1] Includes gross proceeds of $555,811, less $44,465 cash offering costs.
[2] Includes gross proceeds of $927,060 less $74,972 offering costs.
[3] Represents $1,609,935 relative fair value of warrants, less $103,616 of allocable issuance costs.